Evercon 0.25 mg table is an immunosuppresent medication containing Everolimus, used primarily to prevent organ transplant rejection (kidney, liver) and treat specific cancers (kidney, breast ,neuroendocrine tumors ) by inhibiting the mTOR pathway . it suppresses the organ acceptance and slow cancer cell reproduction . it is used to stop the immune system from attacking kidney or liver tissues, often in combination with drugs like cyclosporine or tracrolimus. The mechanistic target of rapamycin (mTOR) act as a central metabolic hub regulating cell growth proliferation and survival , making it a critical therapeutic target in modern oncology. 

WHAT IS EVERCON 0.25 MG TABLETS?

Evercon 0.25 mg is an anti cancer and immunosuppressant medication containing Everolimus. It act as an mTOR inhibitor which works by limiting blood supply to tumors to slow cancer cell growth and suppressing the immune system to prevent organ transplant rejection.

Key classification :

• • Mechanism of action: it inhibit the mTOR protein kinase, which reduces cell proliferation, angiogenesis and immune cell activity.

• Cancer treatment (Antineoplastic) used to treat various cancers, including certain neuroendocrine tumors, renal cell carcinoma, and breast cancer.

• Transplant medicine(immunosuppressant): used under brand names like zortress to prevent rejection in kidney and heart transplants.

• Other uses: used to treat tuberous sclerosis complex (TSC) –related tumors and seizures.

WHAT ARE THE MEDICAL USES OF EVERCON 0.25 MG ?

Medical uses of Evercon 0.25 MG are:

1. Treatment of certain types of Breast cancer

evercon 0.25 mg tablet is an anti cancer medication primarily used in combination with other medicines to treat advance hormone receptor –positive (HR+) ,HER2-negative breast cancer that has spread to other parts of the body. It is categorized as an mTOR inhibitor or kinase inhibitor , which works by inhibiting the mTOR protein, thereby slowing down the growth and spread of cancer cells and reducing the blood supply to the tumor.

2. Neuroendocrine tumors

Evercon 0.25 mg tablet is an mTOR inhibitor used to treat advanced neuroendocrine tumors (NETs) of pancreatic , lung and gastrointestinal origin, often when surgery is not possible. It works by inhibiting cell growth and reducing the blood supply to tumors. It is also used to prevent organ transplant rejections. It is used for progressive , unresectable , locally advanced or metastatic neuroendocrine tumors of pancreatic origin (pNET) and non-functional GI/lung NETS. Requires proper monitoring for stomatitis, blood glucose levels and infection risk. It is unsafe during pregnancy.

3. kidney cancer (renal cell carcinoma) 

Evercon 0.25 mg tablet is an mTOR inhibitor used to treat advanced kidney cancer when other treatments have failed. It works by reducing the blood supply to tumors, slowing growth and spread. It acts by restricting blood supply to the tumor and slowing cancer cell growth . It is often prescribed when previous treatment have failed, and it helped manage organ rejection in patients. It targets mammalian target of rapamycin (mTOR) protein to inhibit tumor growth . it is used for advanced renal cell carcinoma . Must be taken strictly as prescribed by an oncologist , often with regular blood monitoring . it is not recommended for severe liver disease ,and it can cause harm to a fetus.

WHAT ARE THE BENEFITS OF EVERCON 0.25 MG TABLETS?

Benefits of Evercon 0.25 mg tablets:

1. Targets cancer cells specifically

Ecercon 0.25 mg tablet contains Everolimus ,a targated antineoplastic medication that works by blocking the mTOR protein. This mechanism reduces the blood supply to the tumor and slows down the growth and spread of cancer cells. It is used when previous treatments have failed. It is often used in combination with other medicines. It is specifically used to treat lungs and gastrointestinal tract that cannot be removed by surgery.

2. Helps slows tumor growth

https://www.cdc.gov/niosh/reproductive-health/prevention/antineoplastic.htmlEvercon 0.25 mg is a prescription medication used as a targeted therapy to slow or inhibit tumor growth in several types of cancers. It works by inhibiting the mTOR (mammalian target of rapamycin) protein, which regulates cell growth and blood vessel development in tumors. It is used for advanced hormone receptor-positive breast cancer, pancreatic neuroendocrine tumors, and renal cell carcinoma. It is also used to prevent organ rejection in kidney and liver transplant patients by suppressing the immune system .

3. Can be used in combination with other therapies

Evercon 0.25 mg tablet, is designed to be used in combination with other therapies for both transplant management and cancer treatment . it is an mTOR inhibitor that suppress the immune system and act as an anti cancer agent. It is frequently prescribed alongside other medications to prevent the body from rejecting a transplanted organ . 

4. Improves Disease control in certain cancers

Evercon 0.25 mg is an antineoplastic medication that improves disease control in certain advanced cancers by inhibiting the mTOR pathway ,which regulates cell growth, division and metabolism . it is specifically used to slow the progression of tumors in breast ,kidney ,lung and pancreatic cancers, as well as in specific genetic disorders, often in combination with other therapeutic agents. It is also used in combination with other medicies for postmenopausal women with hormone receptor –positive, HER-2 –negative cancer that has spread or progressed. It is also used to treat specific benign brain tumors and renal angiomyoliopmas.

WHAT ARE THE POSSIBLE SIDE EFFECTS OF EVERCON 0.25 MG TABLETS?

Side effects of Evercon 0.25 mg tablets are:

• Mouth ulcers,

• Fatigue

• Diarrhea

• Decreased appetite

• Elevated blood sugar or cholesterol levels

CONCLUSION

Evercon 0.25 mg is an immunosuppressant and antineoplastic medication primarily used to prevent organ rejection in transplant patients and treat specific cancers. It works by inhibiting the mTOR kinase to manage cell growth . it is used primarily to prevent kidney/liver transplant rejections and treats advanced breast/kidney cancer.

FREQUENTLY ASKED QUESTIONS (FAQs)

QUESTION: HOW LONG SHOULD EVERCON BE TAKEN?

Evercon 0.25 mg is typically taken for as long as it provides clinical benefit or until side effects become manageable. There is no specific set duration and is often taken long-term on a daily basis as prescribed by a physician .

QUESTION: IS IT CHEMOTHERAPY OR TARGATED THERAPY?

Chemotherapy target all fast growing cells ,both cancerous and healthy ,often causing broad side effects like hair loss. Targated therapy is a precise ‘’precision medicine ‘’ that attacks specific molecules /genes responsible for cancer growth, generally leaving healthy cells unharmed and leading to different side effects

QUESTION: CAN IT CURE CANCER?

Evercon 0.25 mg contains the active ingredient everolimus . while it is potent anti cancer medication, it is not typically described as a ‘’cure for cancer’’ rather, it is used to manage and treat specific advanced or metastatic cancers.

REFRENCES:

1.https://www.truemeds.in/medicine/evercon-025-mg-tablet-10-tm-tacr1-055642

2.https://mcareexports.com/our-products/evercon-tablet-0-25mg-everolimus/

3.https://hubpharmafrica.com/product/evercon-0-25mg-x10-tablets/